文献速递糖尿病

血清镁与2型糖尿病心力衰竭、房颤及微血管并发症呈负相关

Serum Magnesium Is Inversely Associated With Heart Failure, Atrial Fibrillation, and Microvascular Complications in Type 2 Diabetes.
PubMed 文献 · Diabetes Care · 2021-06-18

该研究在4348例2型糖尿病患者中分析血清镁与宏血管病变、死亡、房颤及微血管并发症的前瞻性关联,采用Cox回归并校正混杂因素。随访6.1年发现血清镁与主要宏血管事件、心衰和房颤呈负相关;随访5.1年与整体微血管事件、慢性肾病、糖尿病视网膜病变和糖尿病足呈负相关,HbA1c部分介导了心衰及微血管并发症的关联。

要点

  • 血清镁与心衰风险呈负相关(HR 0.76,95%CI 0.62-0.93)。
  • 血清镁与房颤风险呈负相关(HR 0.59,95%CI 0.49-0.72)。
  • 血清镁与整体微血管事件呈负相关(HR 0.85,95%CI 0.78-0.91)。

核心结论

  • 血清镁浓度与2型糖尿病发生心衰和房颤的风险呈负相关。
  • 血清镁与慢性肾病、糖尿病视网膜病变和糖尿病足并发症的发生呈负相关。
  • 血糖控制部分介导了血清镁与心衰及微血管并发症的关联。

研究设计与样本

  • 研究分析4348名参与者的血清镁与宏血管疾病、死亡、房颤及微血管并发症的关联。
  • 采用Cox回归模型并校正混杂因素。
  • 进行中介分析评估HbA1c是否介导上述关联。

主要发现

  • 基线血清镁平均浓度为0.80±0.08 mmol/L。
  • 随访6.1年期间,血清镁与主要宏血管事件呈负相关(HR 0.87,95%CI 0.76-1.00)。
  • 血清镁与心衰呈负相关(HR 0.76,95%CI 0.62-0.93),与房颤呈负相关(HR 0.59,95%CI 0.49-0.72)。
  • 血清镁与急性心肌梗死、冠心病、脑血管意外和外周动脉疾病无关联。
  • 随访5.1年期间,血清镁与整体微血管事件呈负相关(HR 0.85,95%CI 0.78-0.91);慢性肾病HR 0.89(95%CI 0.82-0.96),糖尿病视网膜病变HR 0.77(95%CI 0.61-0.98),糖尿病足HR 0.85(95%CI 0.78-0.92)。

关键数值与推荐

  • 血清镁与主要宏血管事件关联的HR为0.87(95%CI 0.76-1.00)。
  • 血清镁与心衰关联的HR为0.76(95%CI 0.62-0.93)。
  • 血清镁与房颤关联的HR为0.59(95%CI 0.49-0.72)。
  • 血清镁与整体微血管事件关联的HR为0.85(95%CI 0.78-0.91)。

临床怎么用

  • 在2型糖尿病管理中可关注血清镁水平,其与心衰、房颤及微血管并发症风险呈负相关。
  • 改善血糖控制可能部分影响血清镁与心衰及微血管并发症的关联。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: We investigated whether serum magnesium (Mg2+) was prospectively associated with macro- or microvascular complications and mediated by glycemic control (hemoglobin A1c [HbA1c]), in type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS: We analyzed in 4,348 participants the association of serum Mg2+ with macrovascular disease and mortality (acute myocardial infarction [AMI], coronary heart disease [CHD], heart failure [HF], cerebrovascular accident [CVA], and peripheral arterial disease [PAD]), atrial fibrillation (AF), and microvascular complications (chronic kidney disease [CKD], diabetic retinopathy, and diabetic foot) using Cox regression, adjusted for confounders. Mediation analysis was performed to assess whether HbA1c mediated these associations. RESULTS: The average baseline serum Mg2+ concentration was 0.80 ± 0.08 mmol/L. During 6.1 years of follow-up, serum Mg2+ was inversely associated with major macrovascular, 0.87 (95% CI 0.76; 1.00); HF, 0.76 (95% CI 0.62; 0.93); and AF, 0.59 (95% CI 0.49; 0.72). Serum Mg2+ was not associated with AMI, CHD, CVA, and PAD. During 5.1 years of follow-up, serum Mg2+ was inversely associated with overall microvascular events, 0.85 (95% CI 0.78; 0.91); 0.89 (95% CI 0.82; 0.96) for CKD, 0.77 (95% CI 0.61; 0.98) for diabetic retinopathy, and 0.85 (95% CI 0.78; 0.92) for diabetic foot. HbA1c mediated the associations of serum Mg2+ with HF, overall microvascular events, diabetic retinopathy, and diabetic foot. CONCLUSIONS: Serum Mg2+ concentration is inversely associated with the risk to develop HF and AF and with the occurrence of CKD, diabetic retinopathy, and foot complications in T2D. Glycemic control partially mediated the association of serum Mg2+ with HF and microvascular complications.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Oost LJ, van der Heijden AAWA, Vermeulen EA, et al. Serum Magnesium Is Inversely Associated With Heart Failure, Atrial Fibrillation, and Microvascular Complications in Type 2 Diabetes. Diabetes Care. 2021. PMID: 34385344. doi:10.2337/dc21-0236

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。